RenovoRx Inc. has announced that new clinical data supporting its TAMP™ Therapy Platform will be presented at the 2026 Society of Interventional Oncology $(SIO)$ Annual Scientific Meeting on February 6, 2026. The study, titled "Real-Time Intravascular Pressure Measurements During Double Balloon Catheter-Mediated Trans-Arterial Micro-Perfusion to Optimize Drug Delivery in Solid Tumors," explores a method for measuring intra-arterial pressure during procedures using the RenovoCath®, an adjustable, double-balloon drug-delivery device. The findings show that a simplified, external pressure transducer provides reliable intra-arterial pressure measurements during TAMP procedures, with results indicating that procedural variables such as catheter balloon spacing and vessel diameter can influence peak intra-arterial pressure. The clinical data have not yet been presented and will be shared during the SIO 2026 meeting.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. RenovoRx Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9648542-en) on February 04, 2026, and is solely responsible for the information contained therein.